Trial of Oral SNC-102 in Subjects With Combat-Related Posttraumatic Stress Disorder
Phase 2
Withdrawn
- Conditions
- Post-Traumatic Stress DisordersPosttraumatic Stress DisordersStress Disorders, Post-TraumaticPost-Traumatic Stress Disorders, Combat-related
- Interventions
- First Posted Date
- 2015-03-10
- Last Posted Date
- 2016-04-18
- Lead Sponsor
- Synchroneuron Inc.
- Registration Number
- NCT02384369
A Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of SNC-102 in Subjects With Tourette Syndrome
- First Posted Date
- 2014-08-15
- Last Posted Date
- 2021-04-13
- Lead Sponsor
- Synchroneuron Inc.
- Registration Number
- NCT02217007
- Locations
- 🇺🇸
North Shore University Hospital, Dept. of Psychiatry, Manhasset, New York, United States
🇺🇸Rush University Medical Center, Chicago, Illinois, United States
A Phase 2 Trial Evaluating SNC-102 in Drug-Induced Tardive Dyskinesia
- First Posted Date
- 2014-02-17
- Last Posted Date
- 2021-04-13
- Lead Sponsor
- Synchroneuron Inc.
- Registration Number
- NCT02064010
- Locations
- 🇺🇸
UCLA - Greater Los Angeles, Los Angeles, California, United States
© Copyright 2025. All Rights Reserved by MedPath